Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AARP New York
AARP Statement on Governor's Bill for Prescription Drug Marketing Reform and Transparency
June 1st, 2008
AARP strongly believes New York has a paramount interest in passing the Governor's prescription marketing reform proposals which address the undue influence that pharmaceutical companies have over prescribing decisions that affect not only consumers' pocket books but the treatment they receive. The reforms include banning gifts of over $50 (excluding free samples) to doctors and requiring speakers at continuing medical education programs for health professionals to disclose any financial relationships they might have with a drug company. AARP strongly supports provisions in the proposed legislation to make the business transactions of pharmaceutical...
Source: Pharma Investments, Ventures & Law Weekly (2008-06-01)
|
